IDYA

IDEAYA Biosciences (IDYA)

IDEAYA Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IDYA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/03	19 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/06/03	19 : 00	PR Newswire (US)	IDEAYA Announces Results for Darovasertib Phase 2 IST in Neoadjuvant Uveal Melanoma at ASCO and Clinical Update for Phase 2 Company-Sponsored Neoadjuvant Study	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/06/01	05 : 54	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/06/01	05 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/06/01	05 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/05/31	19 : 00	PR Newswire (US)	IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/05/30	06 : 02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/05/29	19 : 00	PR Newswire (US)	IDEAYA Biosciences to Participate in Upcoming June 2024 Investor Relations Events	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/05/28	19 : 00	PR Newswire (US)	IDEAYA Biosciences Appoints Daniel A. Simon as Chief Business Officer to Lead Corporate Strategy and Business Development	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/05/24	10 : 21	PR Newswire (US)	/C O R R E C T I O N -- IDEAYA Biosciences, Inc./	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/05/24	06 : 05	PR Newswire (US)	IDEAYA Biosciences Announces Abstract Summary Results of ASCO 2024 Oral Presentation for Phase 2 Investigator Sponsored Study of Darovasertib in Neoadjuvant Uveal Melanoma	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/05/07	19 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/05/07	19 : 00	PR Newswire (US)	IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/05/01	19 : 00	PR Newswire (US)	IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations Event	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/04/26	19 : 00	PR Newswire (US)	IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/04/24	23 : 05	PR Newswire (US)	IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/04/22	19 : 00	PR Newswire (US)	IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/04/05	19 : 00	PR Newswire (US)	IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/04/01	19 : 00	PR Newswire (US)	IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Event	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/03/12	19 : 00	PR Newswire (US)	IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/03/05	07 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/03/05	07 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/03/05	07 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/03/04	20 : 00	PR Newswire (US)	IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/02/21	06 : 31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/02/20	20 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/02/20	20 : 00	PR Newswire (US)	IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/02/14	20 : 44	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/02/14	09 : 31	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IDYA	IDEAYA Biosciences Inc
2024/02/14	06 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IDYA	IDEAYA Biosciences Inc